In this study, we designed a dual CAR approach for targeting BCMA and SLAMF7 in MM cells through the development of a modular CAR platform based on split intein-mediated protein splicing, which we named CARtein system. The gene discussed is TNFRSF17; the disease is Miyoshi myopathy.